Vanda Pharmaceuticals (VNDA) Other financing activities (2010 - 2018)

Vanda Pharmaceuticals has disclosed Other financing activities across 7 years of filings, most recently posting $2.7 million for Q1 2018.

• Other financing activities for Q1 2018 came in at $2.7 million, up 20.69% year-over-year; the trailing twelve-month figure through Mar 2018 was $5.7 million (down 42.55% YoY), and the FY2017 annual result was $5.3 million, down 32.25% from the prior year.
• Other financing activities came in at $2.7 million for Q1 2018 at Vanda Pharmaceuticals, up from $81000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $5.9 million in Q3 2016 to a low of -$2.2 million in Q4 2014.
• The 5-year median for Other financing activities is $750000.0 (2016), against an average of $1.2 million.
• Peak annual rise in Other financing activities reached 122300.0% in 2014, while the deepest fall reached 559.43% in 2014.
• Vanda Pharmaceuticals' Other financing activities stood at -$2.2 million in 2014, then jumped by 282.52% to $4.1 million in 2015, then plunged by 81.67% to $750000.0 in 2016, then plunged by 89.2% to $81000.0 in 2017, then soared by 3191.36% to $2.7 million in 2018.
• The last three Other financing activities figures came in at $2.7 million (Q1 2018), $81000.0 (Q4 2017), and $768000.0 (Q3 2017), per Business Quant data.